U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159503) titled 'VISOR Versus PCNL for Treatment of 2-4cm Renal Stones' on Aug. 29.
Brief Summary: The goal of this clinical trial is to learn if the Vortex Intelligence Stone Optimized Removal (VISOR) works safely and effectively to treat kidney stones that are 2 to 4 centimeters in size in kidney. This study will also look at how VISOR compares to the standard surgery, percutaneous nephrolithotomy (PCNL).
The main questions it aims to answer are:
How many participants are stone-free within 24 hours after surgery?
How many participants are stone-free 1 month after surgery?
What side effects or problems, such as pain, fever, or ureter injury, ha...